Intuitive Surgical, Inc. (ISRG)
NasdaqGS: ISRG
· 即時價格 · USD
369.15
+8.69 (2.41%)
收盤價: Sep 11, 2026, 3:59 PM
368.70
-0.12%
盤後: 7:58 PM
股價、關鍵數字和最新消息,都在這一頁。
Intuitive Surgical, Inc.(ISRG)股價、分析與資料
2.41% (1D)
| 買價 | 350 |
| 市值 | 132B |
| 營收 (ttm) | 11B |
| 淨利(ttm) | 3.14B |
| 1.47 | |
| 8.72 | |
| 42.33 | |
| 30.53 | |
| P/B (ttm) | 7.19 |
| P/S (ttm) | 11.99 |
| 財報日期 | Oct 20, 2026 |
| 賣價 | 361.42 |
| 成交量 | 3,348,733 |
| 20 日平均成交量 | 3,041,353 |
| 開盤價 | 363.56 |
| 前收盤價 | 360.46 |
| 當日區間 | 363.56 - 374.48 |
| 52 週範圍 | 328.57 - 603.88 |
| 分析師 | 購買 |
| 目標價 | 484 (31.11%) |
| 股利 | n/a |
| 除息日 | n/a |
關於 ISRG
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedu...
完整的公司簡介財報驚奇
Intuitive Surgical 已於 Jul 16, 2026 公布季度財報:
- 營收為 $2.89B 低於預期 $0, 年增 18.54% 成長.
- 每股盈餘為 2.8 超出預期 0.30, 年增 27.85% 成長.




